Connection

Mohamad Mohty to Antineoplastic Agents, Alkylating

Back to Details
This is a "connection" page, showing publications Mohamad Mohty has written about Antineoplastic Agents, Alkylating.
Mohamad Mohty
Connection Strength
0.595
Antineoplastic Agents, Alkylating
  1. Management of patients with multiple myeloma during the COVID-19 pandemic. Lancet Haematol. 2020 06; 7(6):e435-e437.
    View in: PubMed
    Score: 0.207
  2. Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors. Biol Blood Marrow Transplant. 2018 05; 24(5):1013-1021.
    View in: PubMed
    Score: 0.176
  3. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer. 2017 Jul 15; 123(14):2671-2679.
    View in: PubMed
    Score: 0.167
  4. Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. Am J Hematol. 2018 07; 93(7):859-866.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.